Lennar shares rise as investors digest Q1 results and upbeat Q2 delivery outlook

Lennar Corporation (LEN) is up 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move higher appears tied to Lennar’s fiscal Q1 2026 update and its Q2 outlook, which pointed to higher deliveries and modest margin improvement as the spring selling season begins. After a notable pre-earnings pullback in the prior week, the stock may also be seeing a relief bounce as investors focus on order stability, liquidity, and continued buybacks.

Details:

Lennar reported fiscal Q1 2026 EPS of $0.93 (and $0.88 excluding mark-to-market gains on technology investments) on total revenue of $6.6 billion.

Operational metrics showed new orders up 1% year over year to 18,515 homes, with backlog at 15,588 homes valued at about $6.0 billion.

Management guided fiscal Q2 2026 deliveries of roughly 20,000–21,000 homes, with home sales gross margin expected at 15.5%–16.0% (up from 15.2% in Q1).

The company repurchased 2 million shares for $237 million during the quarter and ended with $2.1 billion of homebuilding cash and no borrowings on its revolving credit facility.

Sources:

Lennar Investor Relations, Trefis, Zacks Investment Research

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$LEN Hedge Fund Activity

We have seen 367 institutional investors add shares of $LEN stock to their portfolio, and 651 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 3,841,881 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $484,230,681
BLACKROCK, INC. removed 3,102,893 shares (-14.6%) from their portfolio in Q4 2025, for an estimated $318,977,400
BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 3,046,240 shares (-64.4%) from their portfolio in Q4 2025, for an estimated $313,153,472
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,958,618 shares (-75.9%) from their portfolio in Q4 2025, for an estimated $304,145,930
FMR LLC removed 2,774,753 shares (-46.3%) from their portfolio in Q4 2025, for an estimated $285,244,608
JPMORGAN CHASE & CO removed 2,719,284 shares (-48.2%) from their portfolio in Q4 2025, for an estimated $279,542,395
VIKING GLOBAL INVESTORS LP removed 2,523,594 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $318,073,787

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$LEN Congressional Stock Trading

Members of Congress have traded $LEN stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $LEN stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 01/09, 12/19.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$LEN Analyst Ratings

Wall Street analysts have issued reports on $LEN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 4 firms issue sell ratings.

Here are some recent analyst ratings:

Evercore ISI Group issued a "Underperform" rating on 12/18/2025
JP Morgan issued a "Underweight" rating on 12/18/2025
UBS issued a "Buy" rating on 12/18/2025
Barclays issued a "Underweight" rating on 12/18/2025
Raymond James issued a "Underperform" rating on 09/22/2025
JMP Securities issued a "Market Outperform" rating on 09/22/2025

To track analyst ratings and price targets for $LEN, check out Quiver Quantitative's $LEN forecast page.

$LEN Price Targets

Multiple analysts have issued price targets for $LEN recently. We have seen 12 analysts offer price targets for $LEN in the last 6 months, with a median target of $107.5.

Here are some recent targets:

Jonathan Bettenhausen from Truist Securities set a target price of $110.0 on 03/04/2026
Anthony Pettinari from Citigroup set a target price of $113.0 on 01/08/2026
Sam Reid from Wells Fargo set a target price of $105.0 on 01/06/2026
John Lovallo from UBS set a target price of $122.0 on 01/06/2026
Rafe Jadrosich from B of A Securities set a target price of $95.0 on 12/18/2025
Michael Rehaut from JP Morgan set a target price of $80.0 on 12/18/2025
Jade Rahmani from Keefe, Bruyette & Woods set a target price of $115.0 on 12/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.